CK Life Sciences Intl Holdings Inc (0775.HK)
Company Info
Highlights
HK$8.07B
HK$2.64B
HK$435.10M
HK$198.66M
HK$0.32 - HK$1.10
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
Loading data...
Returns By Period
CK Life Sciences Intl Holdings Inc (0775.HK) returned 104.88% year-to-date (YTD) and 84.62% over the past 12 months. Over the past 10 years, 0775.HK returned 0.83% annually, underperforming the S&P 500 benchmark at 10.46%.
0775.HK
104.88%
75.00%
82.61%
84.62%
-2.35%
0.83%
^GSPC (Benchmark)
-3.77%
7.44%
-5.60%
8.37%
14.12%
10.46%
Monthly Returns
The table below presents the monthly returns of 0775.HK, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | 26.83% | -3.85% | 8.00% | 66.67% | -6.67% | 104.88% | |||||||
| 2024 | -14.52% | -10.38% | -29.47% | 11.94% | -2.67% | -10.96% | 4.62% | 2.94% | 18.57% | 9.64% | -5.49% | -4.65% | -33.87% |
| 2023 | 2.53% | -1.23% | -5.00% | 3.95% | -0.27% | -2.56% | 1.32% | -5.19% | -4.11% | 0.00% | -10.00% | -1.59% | -20.73% |
| 2022 | -2.70% | -2.78% | -11.42% | -4.85% | 6.73% | 29.03% | 0.00% | -13.75% | -10.14% | -4.84% | 16.95% | 14.49% | 8.43% |
| 2021 | -1.13% | -0.00% | -5.75% | -3.66% | -3.83% | 18.66% | -8.98% | 0.00% | -9.88% | -0.00% | -1.38% | 2.78% | -14.82% |
| 2020 | -6.90% | 18.52% | -3.12% | 7.52% | -7.06% | 1.08% | 9.68% | -11.77% | -1.11% | -7.86% | 17.07% | -8.34% | 2.17% |
| 2019 | 15.09% | 9.52% | -3.27% | 2.25% | -8.82% | 7.41% | -9.19% | -6.32% | -4.06% | 0.00% | 97.19% | 24.28% | 144.20% |
| 2018 | 3.34% | -3.23% | -5.00% | 0.00% | 1.79% | -5.26% | -1.85% | -5.66% | -4.00% | -17.72% | -6.32% | -1.37% | -38.09% |
| 2017 | -1.45% | 4.42% | -7.05% | -1.52% | 1.63% | 1.53% | -3.03% | -4.69% | -0.00% | -1.63% | -0.00% | -0.00% | -11.64% |
| 2016 | -12.85% | -1.64% | 5.01% | 17.46% | -1.51% | -2.78% | 1.43% | 0.00% | 0.00% | -4.23% | 5.89% | -4.17% | -0.21% |
| 2015 | 1.26% | -3.75% | -3.89% | 20.27% | 5.38% | -9.67% | -8.34% | -14.29% | 4.55% | 5.79% | -0.00% | -4.12% | -10.64% |
| 2014 | 5.56% | 2.64% | 2.56% | -2.49% | -2.95% | 1.33% | 1.31% | 5.19% | -1.23% | 2.50% | -1.22% | -2.47% | 10.74% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
With an overall rank of 94, 0775.HK is among the top 6% of stocks on our website when it comes to balancing risk and reward. Below is a breakdown of how it compares using common performance measures.
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for CK Life Sciences Intl Holdings Inc (0775.HK) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Loading data...
Dividends
Dividend History
CK Life Sciences Intl Holdings Inc provided a 0.00% dividend yield over the last twelve months, with an annual payout of HK$0.00 per share.
| Period | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend | HK$0.00 | HK$0.00 | HK$0.01 | HK$0.01 | HK$0.01 | HK$0.01 | HK$0.01 | HK$0.01 | HK$0.01 | HK$0.01 | HK$0.01 | HK$0.01 |
Dividend yield | 0.00% | 0.00% | 1.29% | 1.27% | 1.35% | 1.14% | 1.15% | 2.74% | 1.67% | 1.30% | 1.14% | 0.89% |
Monthly Dividends
The table displays the monthly dividend distributions for CK Life Sciences Intl Holdings Inc. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | |||||||
| 2024 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 |
| 2023 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.01 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.01 |
| 2022 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.01 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.01 |
| 2021 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.01 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.01 |
| 2020 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.01 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.01 |
| 2019 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.01 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.01 |
| 2018 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.01 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.01 |
| 2017 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.01 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.01 |
| 2016 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.01 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.01 |
| 2015 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.01 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.01 |
| 2014 | HK$0.01 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.01 |
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading data...
Worst Drawdowns
The table below displays the maximum drawdowns of the CK Life Sciences Intl Holdings Inc. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the CK Life Sciences Intl Holdings Inc was 90.22%, occurring on Oct 22, 2008. The portfolio has not yet recovered.
The current CK Life Sciences Intl Holdings Inc drawdown is 47.50%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -90.22% | Jul 19, 2002 | 1545 | Oct 22, 2008 | — | — | — |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading data...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of CK Life Sciences Intl Holdings Inc over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Earnings Per Share
The chart presents the Earnings Per Share (EPS) performance of CK Life Sciences Intl Holdings Inc, comparing actual results with analytics estimates.
Valuation
The Valuation section provides an overview of how CK Life Sciences Intl Holdings Inc is priced in the market compared to other companies in the Biotechnology industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PEG Ratio
The chart shows the Price/Earnings to Growth (PEG) ratio for 0775.HK compared to other companies in the Biotechnology industry. 0775.HK currently has a PEG ratio of 0.0. This PEG ratio is low compared to industry peers, which could indicate the stock is undervalued relative to its expected growth.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for 0775.HK relative to other companies in the Biotechnology industry. Currently, 0775.HK has a P/S ratio of 1.5. This P/S ratio is low compared to the industry average. It may indicate that the stock is undervalued relative to its revenue, or that the market expects slower growth or lower margins.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for 0775.HK in comparison with other companies in the Biotechnology industry. Currently, 0775.HK has a P/B value of 2.3. This P/B ratio is in line with the industry average, suggesting the stock is valued fairly in relation to its book value.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |